{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:56:54Z","timestamp":1790773014314,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMIR"],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Immune Checkpoint Inhibitor (ICI)-induced myelitis is a rare but potentially severe neurological immune-related adverse event. Its diagnosis can\nbe challenging because conventional Magnetic Resonance Imaging (MRI) findings may be subtle or limited. A distinctive case was reported of\nICI-induced myelitis characterized by diffuse spinal cord hypermetabolism on 18F-FDG PET\/CT, demonstrating a \u201chot cord\u201d sign and highlighting\nthe potential value of metabolic imaging in neurological immune-related adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation:<\/jats:title>\n                    <jats:p>A 55-year-old man with clear cell renal cell carcinoma developed progressive neurological symptoms after two cycles of toripalimab combined\nwith axitinib. Contrast-enhanced spinal MRI demonstrated patchy T2 hyperintensity and enhancement at the T11\u2013T12 levels and within the cauda\nequina. 18F-FDG PET\/CT subsequently revealed diffuse increased tracer uptake throughout the spinal cord, with a maximum standardized uptake\nvalue (SUVmax) of 6.06, producing a characteristic \u201chot cord\u201d appearance. Cerebrospinal fluid analysis demonstrated inflammatory changes,\nincluding elevated cell count and protein levels. Based on the clinical history, neurological manifestations, imaging findings, and laboratory results,\nICI-induced myelitis was considered the most likely diagnosis. The patient received high-dose glucocorticoid therapy, after which his neurological\nsymptoms substantially improved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This case demonstrates a characteristic diffuse \u201chot cord\u201d pattern of ICI-induced myelitis on 18F-FDG PET\/CT. PET\/CT may provide\ncomplementary metabolic information to MRI and could facilitate the recognition of ICI-associated inflammatory spinal cord injury, particularly\nwhen MRI abnormalities are limited or nonspecific.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734056499647260921115908","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:56:58Z","timestamp":1790769418000},"source":"Crossref","is-referenced-by-count":0,"title":["Immune Checkpoint Inhibitor-Induced Myelitis Presenting with \u201cHot Cord\u201d Sign on\n                    <sup>18<\/sup>\n                    F-FDG PET\/CT: A Case Report"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0558-2344","authenticated-orcid":true,"given":"Chenyu","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Sichuan University West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Sichuan University West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Sichuan University West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0686-0805","authenticated-orcid":true,"given":"Minggang","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Sichuan University West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3191-0528","authenticated-orcid":true,"given":"Rui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Sichuan University West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Medical Imaging Formerly Current Medical Imaging Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734056499647260921115908","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258753\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734056499647260921115908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:56:59Z","timestamp":1790769419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258753\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734056499647260921115908","relation":{},"ISSN":["1573-4056"],"issn-type":[{"value":"1573-4056","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}